Filing Flows › Koru Medical Systems (KRMD) › Q2 2026 › vs Q2 2025
Koru Medical Systems (KRMD) Q2 2026 vs Q2 2025 (year over year)
Koru Medical Systems's revenue rose $1.9M (+18%) from $10.2M in Q2 2025 to $12.0M in Q2 2026. Gross margin 65.1% against 63.5% (+1.6 pts).
Koru Medical Systems, Q2 2026: revenue $12.0M (+18% year over year), operating margin 5.2%, net earnings $252K, operating cash flow $216K. The chart draws each line against Q2 2025, the increases inside each band.
Margins
| Q2 2026 | Q2 2025 | Change | |
|---|---|---|---|
| Gross margin | 65.1% | 63.5% | +1.6 pts |
| Operating margin | 5.2% | -3.1% | +8.3 pts |
| Net margin | 2.1% | -2.0% | +4.1 pts |
| Free cash flow margin | 0.9% | -4.8% | +5.7 pts |
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $12.0M | $10.2M | $1.9M | +18% |
| Gross profit | $7.8M | $6.5M | $1.4M | +21% |
| Cost of revenue | $4.2M | $3.7M | $480K | +13% |
| Operating profit | $627K | −$313K | $940K | — |
| Operating expenses | $7.2M | $6.8M | $431K | +6% |
| Pre-tax earnings | $258K | −$190K | $448K | — |
| Other expense, net | $369K | −$123K | $492K | — |
| Research & development | $1.1M | $1.2M | −$126K | -11% |
| SG&A | $5.9M | $5.4M | $556K | +10% |
| Other operating costs | $210K | $209K | $1K | +0.3% |
| Net earnings | $252K | −$207K | $459K | — |
| Income tax | $6K | $17K | −$12K | -67% |
| Operating cash sources | $920K | $418K | $502K | +120% |
| Depreciation & amortization | $210K | $209K | $1K | +0.3% |
| Share-based compensation | $458K | $416K | $42K | +10% |
| Working capital & other | $704K | $879K | −$175K | -20% |
| Operating cash flow | $216K | −$460K | $676K | — |
| Free cash flow (OCF − capex) | $108K | −$489K | $597K | — |
| Capital expenditures | $108K | $29K | $79K | +274% |
Questions
How much did Koru Medical Systems's revenue grow year over year in Q2 2026?
Koru Medical Systems's revenue rose $1.9M (+18%) from $10.2M in Q2 2025 to $12.0M in Q2 2026. Gross margin 65.1% against 63.5% (+1.6 pts).